A trial based economic evaluation comparing spinal cord stimulation with best medical treatment in painful diabetic peripheral neuropathy

The objective was to perform an economic evaluation comparing spinal cord stimulation in combination with best medical treatment (SCS) with best medical treatment (BMT) in painful diabetic peripheral neuropathy (PDPN) patients. Alongside a prospective two-center randomized controlled trial, involving 36 PDPN patients with severe lower limb pain, not responding to conventional therapy, an economic evaluation was performed. Incremental cost-effectiveness ratios (ICERs) were based on 1) societal costs and quality-adjusted life years (QALYs) and 2) direct healthcare costs and the number of successfully treated patients, respectively, both with a time horizon of 12 months.

from The Journal of Pain http://ift.tt/2hFd4rI
via IFTTT